Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
7.68
-0.03 (-0.39%)
At close: Feb 3, 2026, 4:00 PM EST
7.60
-0.08 (-1.04%)
After-hours: Feb 3, 2026, 5:44 PM EST

Vir Biotechnology Revenue

Vir Biotechnology had revenue of $240.00K in the quarter ending September 30, 2025, a decrease of -89.92%. This brings the company's revenue in the last twelve months to $16.86M, down -78.55% year-over-year. In the year 2024, Vir Biotechnology had annual revenue of $74.21M, down -13.90%.

Revenue (ttm)
$16.86M
Revenue Growth
-78.55%
P/S Ratio
62.82
Revenue / Employee
$41,324
Employees
408
Market Cap
1.07B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition